Screening and Identifying m6A Regulators as an Independent Prognostic Biomarker in Pancreatic Cancer Based on The Cancer Genome Atlas Database

Table 4

Relationship between molecular characteristics and m6A regulatory gene alteration in PAAD patients.

		Without mutation or CNV	With mutation and CNV
KRAS	Wt	45	75	25.671
	Alteration	1	56
SMAD4	Wt	32	18	52.346
	Alteration	14	113
TP53	Wt	42	39	51.936
	Alteration	4	92
CDKN2A	Wt	42	24	77.551
	Alteration	4	107

value < 0.005.